IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

OTTRIA, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.491
NA - Nord America 2.646
AS - Asia 1.602
SA - Sud America 124
AF - Africa 26
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.913
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.592
GB - Regno Unito 957
IT - Italia 806
CN - Cina 711
SE - Svezia 415
SG - Singapore 306
RU - Federazione Russa 278
DE - Germania 257
NL - Olanda 167
IN - India 137
FR - Francia 94
TR - Turchia 94
JP - Giappone 93
KR - Corea 93
DK - Danimarca 87
BR - Brasile 85
IE - Irlanda 82
UA - Ucraina 79
FI - Finlandia 76
ID - Indonesia 53
CA - Canada 43
ES - Italia 39
HK - Hong Kong 33
EU - Europa 31
PL - Polonia 28
CH - Svizzera 26
BE - Belgio 23
CO - Colombia 20
AU - Australia 18
TW - Taiwan 18
GR - Grecia 15
CZ - Repubblica Ceca 11
AT - Austria 10
MX - Messico 8
PT - Portogallo 8
UZ - Uzbekistan 8
AZ - Azerbaigian 6
CL - Cile 6
EG - Egitto 6
IR - Iran 6
LK - Sri Lanka 6
MY - Malesia 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
SC - Seychelles 5
VN - Vietnam 5
AR - Argentina 4
IL - Israele 4
BD - Bangladesh 3
DZ - Algeria 3
HR - Croazia 3
KZ - Kazakistan 3
LT - Lituania 3
NO - Norvegia 3
ZA - Sudafrica 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
EC - Ecuador 2
EE - Estonia 2
HU - Ungheria 2
JM - Giamaica 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
SA - Arabia Saudita 2
SI - Slovenia 2
TN - Tunisia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
RS - Serbia 1
SD - Sudan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.942
Salva come PNG Salva come JPEG
Città #
Southend 879
Milan 348
Chandler 260
Singapore 224
Seattle 150
Fairfield 138
Wilmington 135
Ashburn 130
Beijing 119
Dearborn 116
Ann Arbor 110
Princeton 103
Council Bluffs 84
Dublin 81
Houston 74
Redwood City 70
Woodbridge 66
Boardman 62
Santa Clara 59
Nanjing 57
Mountain View 54
Cambridge 47
Jakarta 41
Jinan 39
Moscow 39
Helsinki 37
Shanghai 37
Redmond 36
Bengaluru 34
Frankfurt am Main 32
Jacksonville 32
Tokyo 30
Shenyang 29
Phoenix 28
Des Moines 24
Sakarya 24
Somerville 24
Toronto 24
Hangzhou 22
Hebei 21
Hong Kong 21
Berlin 20
Los Angeles 20
Andover 19
Bogotá 19
Guangzhou 19
Warsaw 19
Bodio Lomnago 18
Brussels 18
Serra 18
Falls Church 17
Istanbul 17
Nanchang 16
Seoul 16
Zhengzhou 16
Nuremberg 15
Wuhan 15
Athens 14
San Diego 14
Changsha 13
Fuzhou 13
Eitensheim 12
Silver Spring 12
Groningen 11
Rome 11
Taipei 11
Tianjin 11
Fremont 10
Jiaxing 10
London 10
Munich 10
Stockholm 10
São Paulo 10
Amsterdam 9
Naples 9
Odernheim 9
Pisa 9
Hanover 8
Philadelphia 8
Saint Petersburg 8
Salerno 8
Turin 8
Zurich 8
Medford 7
Ningbo 7
Quanzhou 7
Roxbury 7
Sunnyvale 7
Taizhou 7
Boston 6
Chicago 6
Florence 6
Grafing 6
Hamburg 6
Kent 6
Montague 6
Mumbai 6
Padova 6
Paris 6
Vienna 6
Totale 4.596
Salva come PNG Salva come JPEG
Nome #
LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices : Application to a pharmaco-delivery study 992
A Glycomimetic Compound Inhibits DC-SIGN Mediated HIV Infection in Cellular and Cervical Explant Models 321
H-Ferritin-nanocaged olaparib : a promising choice for both BRCA-mutated and sporadic triple negative breast cancer 238
Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines 232
Quantitative Characterization of Olaparib in Nanodelivery System and Target Cell Compartments by LC-MS/MS 214
17alpha- and 17beta-boldenone 17-glucuronides : synthesis and complete characterization by 1H and 13C NMR 212
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model 210
Set-up and validation of a high throughput screening method for human monoacylglycerol lipase (MAGL) based on a new red fluorescent probe 196
Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage 180
Small-Molecules as Chemiluminescent Probes to Detect Lipase Activity 177
Sintesi e attività biologica di aciclonucleosidi analoghi dell’isopenteniladenosina potenzialmente dotati di attività biologica 177
Effects of cytokinins, cytokinin ribosides and their analogs on the viability of normal and neoplastic human cells 165
Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase 165
N-6-Alkyladenosines: synthesis and evaluation of in vitro anticancer activity 164
1H, 13C and 15N NMR spectral assignments of adenosine derivatives with different amino substituents at C6-position. 164
Quantitative Lipidomic Analysis of Osteosarcoma Cell-Derived Products by {UHPLC}-{MS}/{MS} 163
Synthesis and evaluation of in vitro anticancer activity of some novel isopentenyladenosine derivatives 161
Novel Isopentenyladenosine analogues: synthesis and evaluation of antiproliferative activity 157
Simultaneous ultra-high performance liquid chromathograpy-electrospray ionization-quadrupole-time of flight mass spectrometry quantification of endogenous anandamide and related N-acylethanolamides in bio-matrices 153
Olaparib nanoformulation in H-ferritin as a promising option for both BRCA-mutated and sporadic triple negative breast cancer: An in vitro study 153
H-1, C-13 and N-15 NMR assignments for N-6-isopentenyladenosine/inosine analogues 147
Effects of N6-isopentenyladenosine and Analogues on Bladder Cancer 146
Synthesis of Differently Protected 1-C-Methyl-Ribofuranoses Intermediates for the Preparation of Biologically Active 1'-C-Methyl-Ribonucleosides 141
Pseudosaccharides Functionalized Dendrons Inhibitors of MBL Are Able to Prevent Ischemic Injury In Mice 140
A New Ultrasensitive Bioluminescence-Based Method for Assaying Monoacylglycerol Lipase 137
Novel Isopentenyladenosine Analogues : Synthesis, Characterization, and Evaluation of Antiproliferative Activity on Bladder Carcinoma Cells 134
Studies on the synthesis and the biological activity of nucleosides analogues related to isopentenyladenosine 128
Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia 127
Isopentenyladenosine analogues as potential antitumor agents : synthesis and structure-activity relationships 126
N6-Isopentenyladenosine and its Analogue N6-Benzyladenosine Induce Cell Cycle Arrest and Apoptosis in Bladder Carcinoma T24 Cells 126
Design, synthesis, and biological evaluation of novel N6-Isopentenyladenosine Analogues 125
Plasma endocannabinoid behaviour in total knee and hip arthroplasty 125
Synthesis of multivalent pseudo-mannosides as inhibitors of Mannose Binding Lectin, a potential target in human stroke 124
Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease 124
Clarifying the Use of Benzylidene Protecting Group for D-($mathplus$)-Ribono-1,4-Lactone, an Essential Building Block in the Synthesis of C-Nucleosides 120
Mass quantification of anandamide and related N-acylethanolamides in plasma for clinical investigations 114
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in those with pancreatic ductal adenocarcinoma 111
Simple Synthesis of 17-β-O-hemisuccinate of Stanozolol for Immunoanalytical Methods 109
Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflammatory Bowel Disease: From the Past to the Future 108
Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer 108
1H, 13C and 15N NMR assignments for N- and O-acylethanolamines, important family of naturally occurring bioactive lipid mediators 107
Optimized synthesis and characterization of N-acylethanolamines and O-acylethanolamines, important family of lipid-signalling molecules 104
Pharmacogenomics and analogues of the antitumor agent N6-isopentenyladenosine 102
Mannose binding lectin as a target for cerebral ischemic injury 102
Studies on the synthesis and the biological activity of acyclonucleosides related to isopentenyladenosine 100
Gene expression profile modulation by the antitumor agent N6-isopentenyladenosine and characterization of its analogues 96
Lipid peroxidation inhibition study: A promising case of 1,3-di([1,1′-biphenyl]-3-yl)urea 96
N6-isopentenyladenosine a new potential anti-angiogenic compound that targets human microvascular endothelial cells in vitro 91
2-Arachidonoylglycerol Synthesis: Facile and Handy Enzymatic Method That Allows to Avoid Isomerization 80
Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling 74
Fluorescence-Based Enzyme Activity Assay: Ascertaining the Activity and Inhibition of Endocannabinoid Hydrolytic Enzymes 70
Lipids and lipid signaling molecules in human milk and infant formula, a chemical characterization of relevant biochemical components 48
Placental Bioenergetics and Antioxidant Homeostasis in Maternal Obesity and Gestational Diabetes 45
Pre- to Postbiotics: The Beneficial Roles of Pediatric Dysbiosis Associated with Inflammatory Bowel Diseases 38
Tracing zinc’s role in preterm infants’ health: A narrative review 31
Discovery of MAGL Inhibition by Lophine Derivatives: An Unexpected Finding from Chemiluminescent Assay Development 8
Totale 8.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020249 0 0 0 0 0 0 0 0 0 122 54 73
2020/2021891 22 85 67 40 88 76 57 99 83 92 125 57
2021/2022827 66 48 33 67 81 71 70 50 69 61 73 138
2022/2023978 152 107 84 105 114 154 27 69 87 15 46 18
2023/2024659 23 47 79 43 116 68 32 49 32 54 43 73
2024/20251.427 103 201 58 173 164 106 117 187 123 195 0 0
Totale 8.306